378 related articles for article (PubMed ID: 35011616)
41. Cystic Fibrosis and the Nervous System.
Reznikov LR
Chest; 2017 May; 151(5):1147-1155. PubMed ID: 27876591
[TBL] [Abstract][Full Text] [Related]
42. CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis.
Gould MJ; Smith H; Rayment JH; Machida H; Gonska T; Galante GJ
J Cyst Fibros; 2022 Jul; 21(4):600-602. PubMed ID: 34732308
[TBL] [Abstract][Full Text] [Related]
43. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
Kuk K; Taylor-Cousar JL
Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
[TBL] [Abstract][Full Text] [Related]
44. The changing face of the exocrine pancreas in cystic fibrosis: pancreatic sufficiency, pancreatitis and genotype.
Walkowiak J; Lisowska A; Blaszczyński M
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):157-60. PubMed ID: 18301292
[TBL] [Abstract][Full Text] [Related]
45. CFTR, bicarbonate, and the pathophysiology of cystic fibrosis.
Borowitz D
Pediatr Pulmonol; 2015 Oct; 50 Suppl 40():S24-S30. PubMed ID: 26335950
[TBL] [Abstract][Full Text] [Related]
46. Lumacaftor-rescued F508del-CFTR has a modified bicarbonate permeability.
Ferrera L; Baroni D; Moran O
J Cyst Fibros; 2019 Sep; 18(5):602-605. PubMed ID: 30738802
[TBL] [Abstract][Full Text] [Related]
47. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
[TBL] [Abstract][Full Text] [Related]
48. Pro-inflammatory cytokines stimulate CFTR-dependent anion secretion in pancreatic ductal epithelium.
Angyal D; Groeneweg TA; Leung A; Desain M; Dulla K; de Jonge HR; Bijvelds MJC
Cell Mol Biol Lett; 2024 Jan; 29(1):18. PubMed ID: 38262945
[TBL] [Abstract][Full Text] [Related]
49. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
Reddy MM; Quinton PM
JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
[TBL] [Abstract][Full Text] [Related]
50. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.
Cohn JA; Friedman KJ; Noone PG; Knowles MR; Silverman LM; Jowell PS
N Engl J Med; 1998 Sep; 339(10):653-8. PubMed ID: 9725922
[TBL] [Abstract][Full Text] [Related]
51. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
[TBL] [Abstract][Full Text] [Related]
52. Gating of CFTR by the STAS domain of SLC26 transporters.
Ko SB; Zeng W; Dorwart MR; Luo X; Kim KH; Millen L; Goto H; Naruse S; Soyombo A; Thomas PJ; Muallem S
Nat Cell Biol; 2004 Apr; 6(4):343-50. PubMed ID: 15048129
[TBL] [Abstract][Full Text] [Related]
53. Impaired pancreatic ductal bicarbonate secretion in cystic fibrosis.
Soleimani M
JOP; 2001 Jul; 2(4 Suppl):237-42. PubMed ID: 11875265
[TBL] [Abstract][Full Text] [Related]
54. Impact of hypoxia and AMPK on CFTR-mediated bicarbonate secretion in human cholangiocyte organoids.
Roos FJM; Bijvelds MJC; Verstegen MMA; Roest HP; Metselaar HJ; Polak WG; Jonge HR; IJzermans JNM; van der Laan LJW
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G741-G752. PubMed ID: 33655768
[TBL] [Abstract][Full Text] [Related]
55. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
[TBL] [Abstract][Full Text] [Related]
56. A foetus with cystic fibrosis - To treat or not to treat?
Padmakumar N; Khan HS
Respir Med Res; 2023 Jun; 83():101006. PubMed ID: 37037055
[TBL] [Abstract][Full Text] [Related]
57. Understanding CFTR Functionality: A Comprehensive Review of Tests and Modulator Therapy in Cystic Fibrosis.
Thakur S; Ankita ; Dash S; Verma R; Kaur C; Kumar R; Mazumder A; Singh G
Cell Biochem Biophys; 2024 Mar; 82(1):15-34. PubMed ID: 38048024
[TBL] [Abstract][Full Text] [Related]
58. Cystic fibrosis transmembrane conductance regulator currents in guinea pig pancreatic duct cells: inhibition by bicarbonate ions.
O'Reilly CM; Winpenny JP; Argent BE; Gray MA
Gastroenterology; 2000 Jun; 118(6):1187-96. PubMed ID: 10833494
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological treatment of the ion transport defect in cystic fibrosis.
Roomans GM
Expert Opin Investig Drugs; 2001 Jan; 10(1):1-19. PubMed ID: 11116277
[TBL] [Abstract][Full Text] [Related]
60. Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice.
Zeng M; Szymczak M; Ahuja M; Zheng C; Yin H; Swaim W; Chiorini JA; Bridges RJ; Muallem S
Gastroenterology; 2017 Oct; 153(4):1148-1159. PubMed ID: 28634110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
